Ann Neurol

1. HENG YJ, Jayaraman A, Reynolds R, Foo JN, et al
   Predominance of Ferroptotic Cell Death Mechanisms in Substantia Nigra Neurodegeneration in Parkinson's Disease.
   Ann Neurol. 2026 Mar 10. doi: 10.1002/ana.78202.
   

   >> Share

   
   
2. IBANEZ L, Pottier C, Beric A, Western D, et al
   Understanding Neurodegenerative Diseases From the -Omics Perspective: Lessons Learnt.
   Ann Neurol. 2026;99:566-587.
   

   >> Share

   
   

   
   BMC Neurol

3. YUAN Y, Zhang Z, Shu Z, Wei Y, et al
   Prediction of depression development in Parkinson's disease patients: a radiomics-based machine learning study.
   BMC Neurol. 2026 Mar 12. doi: 10.1186/s12883-026-04779.
   

   >> Share

   
   

   
   Exp Brain Res

4. WANG X, Wang D, Zhang C, Zhang H, et al
   miR-214-3p exacerbates mitochondrial dysfunction in parkinson's disease: a multi-omics and mechanistic study.
   Exp Brain Res. 2026;244:60.
   

   >> Share

   
   

   
   J Biol Chem

5. EALY A, Serapiglia AM, Panicker N
   Sterile innate immune mechanisms in neurodegenerative diseases.
   J Biol Chem. 2026;302:111039.
   

   >> Share

   
   

   
   J Neural Transm (Vienna)

6. SMID A, Elting JWJ, van Laar T, Ten Kate JM, et al
   Perioperative quantification of MDS-UPDRS-III tremor measurements in patients with Parkinson's disease using accelerometry.
   J Neural Transm (Vienna). 2026 Mar 11. doi: 10.1007/s00702-026-03132.
   

   >> Share

   
   

   
   J Neurochem

7. GOLDSTEIN DS, Sullivan P, Holmes C, Kema I, et al
   Emerging Role of Liquid Chromatography-Mass Spectrometry in the Clinical Laboratory Evaluation of Chronic Autonomic Failure.
   J Neurochem. 2026;170:e70405.
   

   >> Share

   
   

   
   J Neurol Neurosurg Psychiatry

8. WANG J, Lam SP, Huang B, Liu Y, et al
   Familial alpha-synucleinopathy spectrum features in patients with psychiatric REM sleep behaviour disorder.
   J Neurol Neurosurg Psychiatry. 2023;94:893-903.
   

   >> Share

   
   

   
   Mov Disord

9. POZZI R, De Sciscio M, Bosetti M, Cano-Crespo S, et al
   Glucocerebrosidase Target Engagement and Therapeutic Plasma and Cerebrospinal Fluid Levels After GT-02287 Administration in Healthy Volunteers.
   Mov Disord. 2026;41:522-527.
   

   >> Share

   
   
10. CORRAL I, Martinez Castrillo JC, Bhatia KP, Garcia Ruiz PJ, et al
    A Pioneering 1915 Film on Movement Disorders in Spain: Parkinsonism, Huntington's Disease, and Paradoxical Kinesia.
    Mov Disord. 2026 Mar 7. doi: 10.1002/mds.70257.
    

    >> Share

    
    
11. ISIK FI, Pickford R, Chua M, Lewis SJG, et al
    Elevation of Stearoyl-Coenzyme A Desaturase and Monounsaturated Fatty Acids in Parkinson's Disease Serum.
    Mov Disord. 2026 Mar 10. doi: 10.1002/mds.70264.
    

    >> Share

    
    
12. STEP K, Hernandez CF, Khani M, Eltaraifee E, et al
    Genome-Wide Assessment Reveals Ancestral Differences in Homozygosity Patterns Potentially Linked to Parkinson's Disease Etiology.
    Mov Disord. 2026 Mar 11. doi: 10.1002/mds.70182.
    

    >> Share

    
    
13. HAMMER LH, Cernera S, Oehrn CR, Yao J, et al
    Stimulation and Medication Effects on Subthalamic Nucleus Beta-Band Power in Parkinson's Disease: Implications for Adaptive Deep Brain Stimulation.
    Mov Disord. 2026 Mar 11. doi: 10.1002/mds.70261.
    

    >> Share

    
    

    
    Nat Rev Neurol

14. GILAT M, Nonnekes J, Factor SA, Bloem BR, et al
    An updated definition of freezing of gait.
    Nat Rev Neurol. 2026 Jan 9. doi: 10.1038/s41582-025-01179.
    

    >> Share

    
    

    
    Nervenarzt

15. BANG C, Heinzel S
    [Relationships between microbiome and neurodegeneration].
    Nervenarzt. 2023;94:885-891.
    

    >> Share

    
    

    
    Neurobiol Dis

16. CHEN K, Ji Y, Zhang R, Lu L, et al
    Linking subjective cognitive decline to glymphatic dysfunction in Parkinson's disease.
    Neurobiol Dis. 2026;221:107344.
    

    >> Share

    
    
17. LAU K, Porschen LT, Richter F, Gericke B, et al
    Microvascular blood-brain barrier alterations in isolated brain capillaries of mice over-expressing alpha-synuclein (Thy1-aSyn line 61).
    Neurobiol Dis. 2023;187:106298.
    

    >> Share

    
    

    
    PLoS Genet

18. STEP K, Ndong Sima CAA, Grant S, Kim JJ, et al
    Polygenic risk scores and Parkinson's disease in South Africa advancing ancestry informed disease prediction.
    PLoS Genet. 2026;22:e1012064.
    

    >> Share

    
    

    
    PLoS One

19. VASCONCELLOS LS, Taveira RS, de Melo LP, de Macedo Borges LRD, et al
    Effects of telerehabilitation-based physical therapy for individuals with Parkinson's disease: A systematic review protocol.
    PLoS One. 2026;21:e0342771.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share